Valiltramiprosate

DB19191InvestigationalSmall molecule

Valiltramiprosate is under investigation in clinical trial NCT06304883 (Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects).

Mechanism: Pharmacologically active on Amyloid-beta precursor protein
Curator reviewed
Formula / weight: C₈H₁₈N₂O₄S · 238.3 g/mol (avg)
Also known as: 1-propanesulfonic acid, 3-(((2s)-2-amino-3-methyl-1-oxobutyl)amino)- · 3-((2s)-2-amino-3-methylbutamido)propane-1-sulfonic acid
Code names: ALZ- 801 · BLU-8499 · NRM-8499

Resolves to

Compound

UNIIGHG2B47067CAS1034190-08-3ChEMBLCHEMBL4650301

Structure

InChIKeyNRZRFNYKMSAZBI-ZETCQYMHSA-NSMILESCC(C)[C@H](N)C(=O)NCCCS(O)(=O)=O

Targets

P05067APP

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Valiltramiprosate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account